These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16641939)

  • 21. Vagus nerve stimulation. A potential therapy for resistant depression?
    George MS; Sackeim HA; Marangell LB; Husain MM; Nahas Z; Lisanby SH; Ballenger JC; Rush AJ
    Psychiatr Clin North Am; 2000 Dec; 23(4):757-83. PubMed ID: 11147246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vagus nerve stimulation acutely alters food craving in adults with depression.
    Bodenlos JS; Kose S; Borckardt JJ; Nahas Z; Shaw D; O'Neil PM; George MS
    Appetite; 2007 Mar; 48(2):145-53. PubMed ID: 17081655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vagus nerve stimulation in depression.
    Goodnick PJ; Rush AJ; George MS; Marangell LB; Sackeim HA
    Expert Opin Pharmacother; 2001 Jul; 2(7):1061-3. PubMed ID: 11583056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vagus Nerve Stimulation for Major Depressive Episodes.
    Eljamel S
    Prog Neurol Surg; 2015; 29():53-63. PubMed ID: 26393819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy.
    Alexopoulos AV; Kotagal P; Loddenkemper T; Hammel J; Bingaman WE
    Seizure; 2006 Oct; 15(7):491-503. PubMed ID: 16859931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vagus nerve stimulation use and effect in epilepsy: what have we learned?
    Tecoma ES; Iragui VJ
    Epilepsy Behav; 2006 Feb; 8(1):127-36. PubMed ID: 16376157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: a case study and cost analysis.
    Warnell RL; Elahi N
    J ECT; 2007 Jun; 23(2):114-9. PubMed ID: 17548984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right-sided vagus nerve stimulation as a treatment for refractory epilepsy in humans.
    McGregor A; Wheless J; Baumgartner J; Bettis D
    Epilepsia; 2005 Jan; 46(1):91-6. PubMed ID: 15660773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurostimulation therapies in depression: a review of new modalities.
    Marangell LB; Martinez M; Jurdi RA; Zboyan H
    Acta Psychiatr Scand; 2007 Sep; 116(3):174-81. PubMed ID: 17655558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-year outcome of vagus nerve stimulation in treatment-resistant depression.
    Bajbouj M; Merkl A; Schlaepfer TE; Frick C; Zobel A; Maier W; O'Keane V; Corcoran C; Adolfsson R; Trimble M; Rau H; Hoff HJ; Padberg F; Müller-Siecheneder F; Audenaert K; van den Abbeele D; Matthews K; Christmas D; Eljamel S; Heuser I
    J Clin Psychopharmacol; 2010 Jun; 30(3):273-81. PubMed ID: 20473062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects.
    Park MC; Goldman MA; Carpenter LL; Price LH; Friehs GM
    Acta Neurochir Suppl; 2007; 97(Pt 2):407-16. PubMed ID: 17691329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.
    Nahas Z; Marangell LB; Husain MM; Rush AJ; Sackeim HA; Lisanby SH; Martinez JM; George MS
    J Clin Psychiatry; 2005 Sep; 66(9):1097-104. PubMed ID: 16187765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?
    Nahas Z; Burns C; Foust MJ; Short B; Herbsman T; George MS
    Curr Psychiatry Rep; 2006 Dec; 8(6):445-51. PubMed ID: 17094924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VNS Therapy versus the latest antiepileptic drug.
    Ben-Menachem E; French JA
    Epileptic Disord; 2005 Sep; 7 Suppl 1():S22-6. PubMed ID: 16120490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical vagus nerve stimulation for treatment-resistant depression.
    Carpenter LL; Friehs GM; Price LH
    Neurosurg Clin N Am; 2003 Apr; 14(2):275-82. PubMed ID: 12856494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.
    Neuhaus AH; Luborzewski A; Rentzsch J; Brakemeier EL; Opgen-Rhein C; Gallinat J; Bajbouj M
    J Affect Disord; 2007 Jun; 100(1-3):123-8. PubMed ID: 17098290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings.
    Labiner DM; Ahern GL
    Acta Neurol Scand; 2007 Jan; 115(1):23-33. PubMed ID: 17156262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of vagus nerve stimulation and deep brain stimulation in depression.
    Mohr P; Rodriguez M; Slavíčková A; Hanka J
    Neuropsychobiology; 2011; 64(3):170-81. PubMed ID: 21811087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in gustatory perceptions of patients with major depression treated with vagus nerve stimulation (VNS).
    Sperling W; Biermann T; Spannenberger R; Clepce M; Padberg F; Reulbach U; Kornhuber J; Thuerauf N
    Pharmacopsychiatry; 2011 Mar; 44(2):67-71. PubMed ID: 21157695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.